2024-04-012025-03-312025-03-31falseSC357104THE GLASGOW SMILE CLINIC LIMITED2025-12-2486230falseiso4217:GBPxbrli:pureSC3571042024-03-31SC3571042025-03-31SC3571042024-04-012025-03-31SC3571042023-03-31SC3571042024-03-31SC3571042023-04-012024-03-31SC357104bus:SmallEntities2024-04-012025-03-31SC357104bus:AuditExempt-NoAccountantsReport2024-04-012025-03-31SC357104bus:FullAccounts2024-04-012025-03-31SC357104bus:PrivateLimitedCompanyLtd2024-04-012025-03-31SC357104core:WithinOneYear2025-03-31SC357104core:AfterOneYear2025-03-31SC357104core:WithinOneYear2024-03-31SC357104core:AfterOneYear2024-03-31SC357104core:ShareCapital2025-03-31SC357104core:SharePremium2025-03-31SC357104core:RevaluationReserve2025-03-31SC357104core:OtherReservesSubtotal2025-03-31SC357104core:RetainedEarningsAccumulatedLosses2025-03-31SC357104core:ShareCapital2024-03-31SC357104core:SharePremium2024-03-31SC357104core:RevaluationReserve2024-03-31SC357104core:OtherReservesSubtotal2024-03-31SC357104core:RetainedEarningsAccumulatedLosses2024-03-31SC357104core:LandBuildings2025-03-31SC357104core:PlantMachinery2025-03-31SC357104core:Vehicles2025-03-31SC357104core:FurnitureFittings2025-03-31SC357104core:OfficeEquipment2025-03-31SC357104core:NetGoodwill2025-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2025-03-31SC357104core:ListedExchangeTraded2025-03-31SC357104core:UnlistedNon-exchangeTraded2025-03-31SC357104core:LandBuildings2024-03-31SC357104core:PlantMachinery2024-03-31SC357104core:Vehicles2024-03-31SC357104core:FurnitureFittings2024-03-31SC357104core:OfficeEquipment2024-03-31SC357104core:NetGoodwill2024-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2024-03-31SC357104core:ListedExchangeTraded2024-03-31SC357104core:UnlistedNon-exchangeTraded2024-03-31SC357104core:LandBuildings2024-04-012025-03-31SC357104core:PlantMachinery2024-04-012025-03-31SC357104core:Vehicles2024-04-012025-03-31SC357104core:FurnitureFittings2024-04-012025-03-31SC357104core:OfficeEquipment2024-04-012025-03-31SC357104core:NetGoodwill2024-04-012025-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-31SC357104core:ListedExchangeTraded2024-04-012025-03-31SC357104core:UnlistedNon-exchangeTraded2024-04-012025-03-31SC357104core:MoreThanFiveYears2024-04-012025-03-31SC357104core:Non-currentFinancialInstruments2025-03-31SC357104core:Non-currentFinancialInstruments2024-03-31SC357104dpl:CostSales2024-04-012025-03-31SC357104dpl:DistributionCosts2024-04-012025-03-31SC357104core:LandBuildings2024-04-012025-03-31SC357104core:PlantMachinery2024-04-012025-03-31SC357104core:Vehicles2024-04-012025-03-31SC357104core:FurnitureFittings2024-04-012025-03-31SC357104core:OfficeEquipment2024-04-012025-03-31SC357104dpl:AdministrativeExpenses2024-04-012025-03-31SC357104core:NetGoodwill2024-04-012025-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-31SC357104dpl:GroupUndertakings2024-04-012025-03-31SC357104dpl:ParticipatingInterests2024-04-012025-03-31SC357104dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-31SC357104core:ListedExchangeTraded2024-04-012025-03-31SC357104dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-31SC357104core:UnlistedNon-exchangeTraded2024-04-012025-03-31SC357104dpl:CostSales2023-04-012024-03-31SC357104dpl:DistributionCosts2023-04-012024-03-31SC357104core:LandBuildings2023-04-012024-03-31SC357104core:PlantMachinery2023-04-012024-03-31SC357104core:Vehicles2023-04-012024-03-31SC357104core:FurnitureFittings2023-04-012024-03-31SC357104core:OfficeEquipment2023-04-012024-03-31SC357104dpl:AdministrativeExpenses2023-04-012024-03-31SC357104core:NetGoodwill2023-04-012024-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-31SC357104dpl:GroupUndertakings2023-04-012024-03-31SC357104dpl:ParticipatingInterests2023-04-012024-03-31SC357104dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-31SC357104core:ListedExchangeTraded2023-04-012024-03-31SC357104dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-31SC357104core:UnlistedNon-exchangeTraded2023-04-012024-03-31SC357104core:NetGoodwill2025-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2025-03-31SC357104core:LandBuildings2025-03-31SC357104core:PlantMachinery2025-03-31SC357104core:Vehicles2025-03-31SC357104core:FurnitureFittings2025-03-31SC357104core:OfficeEquipment2025-03-31SC357104core:AfterOneYear2025-03-31SC357104core:WithinOneYear2025-03-31SC357104core:ListedExchangeTraded2025-03-31SC357104core:UnlistedNon-exchangeTraded2025-03-31SC357104core:ShareCapital2025-03-31SC357104core:SharePremium2025-03-31SC357104core:RevaluationReserve2025-03-31SC357104core:OtherReservesSubtotal2025-03-31SC357104core:RetainedEarningsAccumulatedLosses2025-03-31SC357104core:NetGoodwill2024-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2024-03-31SC357104core:LandBuildings2024-03-31SC357104core:PlantMachinery2024-03-31SC357104core:Vehicles2024-03-31SC357104core:FurnitureFittings2024-03-31SC357104core:OfficeEquipment2024-03-31SC357104core:AfterOneYear2024-03-31SC357104core:WithinOneYear2024-03-31SC357104core:ListedExchangeTraded2024-03-31SC357104core:UnlistedNon-exchangeTraded2024-03-31SC357104core:ShareCapital2024-03-31SC357104core:SharePremium2024-03-31SC357104core:RevaluationReserve2024-03-31SC357104core:OtherReservesSubtotal2024-03-31SC357104core:RetainedEarningsAccumulatedLosses2024-03-31SC357104core:NetGoodwill2023-03-31SC357104core:IntangibleAssetsOtherThanGoodwill2023-03-31SC357104core:LandBuildings2023-03-31SC357104core:PlantMachinery2023-03-31SC357104core:Vehicles2023-03-31SC357104core:FurnitureFittings2023-03-31SC357104core:OfficeEquipment2023-03-31SC357104core:AfterOneYear2023-03-31SC357104core:WithinOneYear2023-03-31SC357104core:ListedExchangeTraded2023-03-31SC357104core:UnlistedNon-exchangeTraded2023-03-31SC357104core:ShareCapital2023-03-31SC357104core:SharePremium2023-03-31SC357104core:RevaluationReserve2023-03-31SC357104core:OtherReservesSubtotal2023-03-31SC357104core:RetainedEarningsAccumulatedLosses2023-03-31SC357104core:AfterOneYear2024-04-012025-03-31SC357104core:WithinOneYear2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-31SC357104core:Non-currentFinancialInstrumentscore:CostValuation2025-03-31SC357104core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-31SC357104core:Non-currentFinancialInstrumentscore:CostValuation2024-03-31SC357104core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-31SC357104core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-31SC357104core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-31SC357104core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-31SC357104core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-31SC357104core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-31SC357104core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-31SC357104core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-31SC357104bus:Director12024-04-012025-03-31SC357104bus:Director22024-04-012025-03-31

THE GLASGOW SMILE CLINIC LIMITED

Registered Number
SC357104
(Scotland)

Unaudited Financial Statements for the Year ended
31 March 2025

THE GLASGOW SMILE CLINIC LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

GARDEE, Jameel, Dr
SHER, Haroon

Registered Address

950 Argyle Street
Glasgow
G3 8LU

Registered Number

SC357104 (Scotland)
THE GLASGOW SMILE CLINIC LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3400,000-
Tangible assets478,39073,533
478,39073,533
Current assets
Stocks54,5734,573
Debtors624,636369,544
Cash at bank and on hand154,045221,398
183,254595,515
Creditors amounts falling due within one year7(217,195)(244,494)
Net current assets (liabilities)(33,941)351,021
Total assets less current liabilities444,449424,554
Creditors amounts falling due after one year8(24,878)(112,377)
Provisions for liabilities10(19,598)(18,383)
Net assets399,973293,794
Capital and reserves
Called up share capital1,0001,000
Profit and loss account398,973292,794
Shareholders' funds399,973293,794
The financial statements were approved and authorised for issue by the Board of Directors on 24 December 2025, and are signed on its behalf by:
GARDEE, Jameel, Dr
Director
SHER, Haroon
Director

Registered Company No. SC357104
THE GLASGOW SMILE CLINIC LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year77
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 24220,000220,000
Additions400,000400,000
At 31 March 25620,000620,000
Amortisation and impairment
At 01 April 24220,000220,000
At 31 March 25220,000220,000
Net book value
At 31 March 25400,000400,000
At 31 March 24--
4.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 24226,83333,342260,175
Additions25,6391,04726,686
At 31 March 25252,47234,389286,861
Depreciation and impairment
At 01 April 24172,15614,486186,642
Charge for year17,0484,78121,829
At 31 March 25189,20419,267208,471
Net book value
At 31 March 2563,26815,12278,390
At 31 March 2454,67718,85673,533
5.Stocks

2025

2024

££
Finished goods4,5734,573
Total4,5734,573
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables1,436-
Other debtors22,019369,544
Prepayments and accrued income1,181-
Total24,636369,544
7.Creditors: amounts due within one year

2025

2024

££
Bank borrowings and overdrafts84,25577,400
Taxation and social security100,49674,808
Finance lease and HP contracts8,9048,904
Other creditors18,74051,248
Accrued liabilities and deferred income4,80032,134
Total217,195244,494
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts18,20096,795
Other creditors6,67815,582
Total24,878112,377
9.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts6,67815,582
10.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)19,59818,383
Total19,59818,383
11.Directors advances, credits and guarantees
At the year end balance of director loan account is: Mr Jameel Gradee NIL (2024 - £340 Cr) Mr Haroon Sher NIL (2024 -£22,411 Dr)